Skip to main content
Addgene

pC034 - LwCas13a-msfGFP-2A-Blast Citations (5)

Originally described in: RNA targeting with CRISPR-Cas13.
Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A, Lander ES, Voytas DF, Ting AY, Zhang F Nature. 2017 Oct 4. doi: 10.1038/nature24049.
PubMed Journal

Articles Citing pC034 - LwCas13a-msfGFP-2A-Blast

Articles
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors. Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD. Cell. 2018 Mar 8. pii: S0092-8674(18)30207-1. doi: 10.1016/j.cell.2018.02.033. PubMed

Associated Plasmids

Effective Downregulation of BCR-ABL Tumorigenicity by RNA Targeted CRISPR-Cas13a. Singh A, Bhatia P. Curr Gene Ther. 2021;21(3):270-277. doi: 10.2174/1566523221666210217155233. PubMed
Integrated analysis of ALK higher expression in human cancer and downregulation in LUAD using RNA molecular scissors. Saifullah, Tsukahara T. Clin Transl Oncol. 2022 Sep;24(9):1785-1799. doi: 10.1007/s12094-022-02835-6. Epub 2022 Apr 29. PubMed
Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages. Johnson MC, Hille LT, Kleinstiver BP, Meeske AJ, Bondy-Denomy J. Mol Cell. 2022 Jun 2;82(11):2161-2166.e3. doi: 10.1016/j.molcel.2022.05.002. Epub 2022 May 26. PubMed

Associated Plasmids

Complex genomic patterns of abasic sites in mammalian DNA revealed by a high-resolution SSiNGLe-AP method. Cai Y, Cao H, Wang F, Zhang Y, Kapranov P. Nat Commun. 2022 Oct 5;13(1):5868. doi: 10.1038/s41467-022-33594-1. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.